Clinical Trial Update: Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of ZEN003694 with nivolumab, with or without ipilimumab, in metastatic and recurrent solid tumors; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor
• Ovarian Cancer

Drugs mentioned

• ZEN003694
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm | Phase 1 | Status: SUSPENDED